Tci Bio
Tci Bio, officially known as Tci Bio Co., Ltd., is a leading biotechnology company headquartered in Taiwan (TW). Founded in 2004, Tci Bio has established itself as a key player in the life sciences industry, focusing on the development and production of high-quality biochemicals and reagents. The company operates primarily in Asia, with a growing presence in global markets. Specialising in custom synthesis and innovative solutions for research and development, Tci Bio offers a unique range of products, including peptides, nucleotides, and small molecules. Their commitment to quality and customer service has earned them a strong reputation among researchers and institutions worldwide. With a focus on advancing scientific discovery, Tci Bio continues to achieve significant milestones, solidifying its position as a trusted partner in the biotechnology sector.
DitchCarbon Score
How does Tci Bio's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tci Bio's score of 51 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Tci Bio's reported carbon emissions
In 2023, TCI Co., Ltd., headquartered in Taiwan (TW), reported total greenhouse gas emissions of approximately 13,415,000 kg CO2e. This figure includes 3,646,000 kg CO2e from Scope 1 emissions, 9,669,000 kg CO2e from Scope 2 emissions, and 5,298,000 kg CO2e from Scope 3 emissions, which encompasses business travel and employee commuting. TCI Co., Ltd. has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 51% by 2030, using 2018 as the base year. Additionally, the company plans to cut its Scope 3 emissions from purchased goods and services by 15% by the same year. These targets align with the Science Based Targets initiative (SBTi) and are designed to support global efforts to limit temperature rise to 1.5°C. Over the years, TCI has demonstrated a commitment to sustainability, with emissions in 2022 recorded at 13,677,000 kg CO2e, reflecting a proactive approach to managing its carbon footprint. The company continues to focus on reducing its environmental impact while maintaining its operational efficiency in the pharmaceuticals, biotechnology, and life sciences sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 2,540,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 6,051,000 | 0,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - | 0,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tci Bio is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
